Treatment-refractory paraneoplastic opsoclonus-myoclonus syndrome in a patient with small-cell carcinoma of the lung

被引：1

作者：

Alkan, Ali ^{[1
]}

Cenikli, Utku ^{[2
]}

Uylas, Selcuk ^{[1
]}

Yilmaz, Mehmet ^{[3
]}

Cakir, Tumay ^{[4
]}

Cetinkaya, Halil ^{[5
]}

Kiran, Alkan ^{[1
]}

Tanriverdi, Ozgur ^{[1
]}

机构：

[1] Mugla Sitki Kocman Univ, Sch Med, Dept Internal Med, Med Oncol Unit, Mugla, Turkey

[2] Mugla Sitki Kocman Univ, Sch Med, Dept Neurol, Mugla, Turkey

[3] Mugla Sitki Kocman Univ, Sch Med, Dept Internal Med, Mugla, Turkey

[4] Mugla Sitki Kocman Univ, Sch Med, Dept Neurol, Intens Care Unit, Mugla, Turkey

[5] Mugla Sitki Kocman Univ, Sch Med, Dept Family Med, Mugla, Turkey

来源：

JOURNAL OF ONCOLOGY PHARMACY PRACTICE | 2020年 / 26卷 / 01期

关键词：

Opsoclonus-myoclonus syndrome; paraneoplastic syndrome; small-cell lung cancer; MANIFESTATION;

D O I：

10.1177/1078155219831366

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Opsoclonus-myoclonus syndrome is a rare disease and traditionally described as "dancing eyes, dancing feet syndrome." It is characterized by opsoclonus (oscillations of the eyes in either horizontally or vertically) and myoclonus (spontaneous jerky movements of the limbs and trunk). There are numerous etiological factors defined such as paraneoplastic, para-infectious, toxic-metabolic, and idiopathic causes. The experience of opsoclonus-myoclonus syndrome in adults is very limited. Here, we present a case of treatment-refractory paraneoplastic opsoclonus-myoclonus syndrome associated with small-cell carcinoma of the lung.

引用

页码：209 / 211

页数：3

共 50 条

[31] Plasmapheresis as an effective treatment for opsoclonus-myoclonus syndrome
Yiu, VWY
Kovithavongs, T
McGonigle, LF
Ferreira, P
PEDIATRIC NEUROLOGY, 2001, 24 (01) : 72 - 74
[32] Paraneoplastic Opsoclonus-Myoclonus Syndrome and Prostate Cancer: First Reported Case
Fromowitz, Ariel
Sharma, Ranita
Nissenblatt, Michael
Copeland, Tabitha
NEUROLOGY, 2020, 94 (15)
[33] Paraneoplastic opsoclonus-myoclonus syndrome with anti-neuronal cytoplasmic autoantibodies
Jen, JC
Lopez, I
Charles, A
DiPatre, PL
Liu, F
Sicotte, N
Cloughesy, T
Baloh, RW
NEUROLOGY, 1998, 50 (04) : A12 - A12
[34] Paraneoplastic opsoclonus associated with small cell lung carcinoma
Dropcho, EJ
NEUROLOGY, 2002, 58 (07) : A46 - A47
[35] Treatment of idiopathic opsoclonus-myoclonus syndrome with intravenous immunoglobulin
Unal, A
Sumer, MM
Atasoy, HT
Atasoy, N
NEUROLOGY INDIA, 2004, 52 (04) : 520 - 521
[36] Sequential fluctuating paraneoplastic ocular flutter-opsoclonus-myoclonus syndrome and Lambert-Eaton myasthenic syndrome in small-cell lung cancer
Simister, Robert J.
Ng, Karl
Lang, Bethan
Beckles, Michael
Chao, David
McCabe, Dominick J. H.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2011, 82 (03): : 344 - 346
[37] Surgical Treatment of Neuroblastoma with Opsoclonus-Myoclonus Syndrome in Children
Han, W.
Wang, H. M.
Qin, H.
PEDIATRIC BLOOD & CANCER, 2016, 63 : S295 - S295
[38] Paraneoplastic Opsoclonus-Myoclonus Syndrome: initial presentation of non-Hodgkins lymphoma
Ashwani Kumar
Walter A. Lajara-Nanson
Robert W. Neilson
Journal of Neuro-Oncology, 2005, 73 : 43 - 45
[39] Paraneoplastic opsoclonus-myoclonus syndrome as a presentation of high grade serous ovarian cancer
Stewart, Kimberly T.
Lee, Joohyun Shaina
Stuart, Gavin
GYNECOLOGIC ONCOLOGY REPORTS, 2019, 30
[40] RITUXIMAB AS A TREATMENT FOR REFRACTORY OPSOCLONUS-MYOCLONUS SYNDROME (OMS) IN NEUROBLASTOMA PATIENTS: A CASE SERIES
Toyohara, Miwako
Kiyotani, Chikako
Morita, Mari
Yasue, Shiho
Yamada, Yuji
Deguchi, Takao
Miyazaki, Osamu
Yoshioka, Takako
Yoneda, Akihiro
Matsumoto, Kimikazu
PEDIATRIC BLOOD & CANCER, 2024, 71 : S15 - S16

← 1 2 3 4 5 →